Co-Authors
This is a "connection" page, showing publications co-authored by Shelli Farhadian and Charles Dela Cruz.
Connection Strength
0.853
-
Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol. 2020 Jun 18; 20(1):248.
Score: 0.222
-
Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2. PLoS Pathog. 2021 06; 17(6):e1009683.
Score: 0.060
-
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva. Emerg Infect Dis. 2021 04; 27(4):1146-1150.
Score: 0.059
-
Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples. Emerg Infect Dis. 2021 04; 27(4).
Score: 0.059
-
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection. PLoS One. 2021; 16(3):e0243291.
Score: 0.059
-
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12; 2(3):263-280.e6.
Score: 0.058
-
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators. J Immunol. 2021 01 15; 206(2):329-334.
Score: 0.057
-
Detection of SARS-CoV-2 RNA by multiplex RT-qPCR. PLoS Biol. 2020 10; 18(10):e3000867.
Score: 0.057
-
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020 09 24; 383(13):1283-1286.
Score: 0.056
-
Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020 12; 588(7837):315-320.
Score: 0.056
-
Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020 08; 584(7821):463-469.
Score: 0.056
-
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020 10; 5(10):1299-1305.
Score: 0.056